CUV 1.38% $14.28 clinuvel pharmaceuticals limited

Ann: Appendix 4E and Annual Report 2022, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,974 Posts.
    lightbulb Created with Sketch. 160
    NPAT is just accounting opinion and easily manipulated
    As evident by Clinuvel results
    The market does not care NPAT fell this year because of above

    EBIT much better
    Cash flow even better
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.